GE, UPMC revolutionise disease detection by digitisation
GE Healthcare, a division of General Electric Company, and the University of Pittsburgh Medical Center (UPMC) recently announced the formation of a new company to improve the speed, efficiency of diagnosis and interpretation of lab results. The new joint company, called Omnyx, LLC, will bring to market digital solutions to shape a new age of patient care and apply those solutions to a science that has relied on glass slides and microscopes for over 125 years. Omnyx is the first company in GE’s history to be formed with an academic medical center and represents an aim to accelerate ideas to market through enhanced co-development. Omnyx’s digital platform will seek to enable clinicians to share images virtually, interpret results using advanced algorithms and reduce costs associated with diagnosis. The benefit to patients could include reducing medical errors, improved turnaround time for lab results and integrating pathology information as part of his or her electronic medical record. GE and UPMC have appointed Gene Cartwright, a 26-year healthcare veteran and former president of GE Healthcare’s molecular diagnostics, as Chief utive Officer of Omnyx. “This new company will revolutionize patient care and expand GE vision for Early Health
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
